TY - JOUR
T1 - Factors associated with provision of addiction treatment information by community pharmacists
AU - Hagemeier, Nicholas E.
AU - Alamian, Arsham
AU - Murawski, Matthew M.
AU - Pack, Robert P.
N1 - Funding Information:
Declaration of Interest: Project Funding Source: East Tennessee State University Research Development Committee Major Grant Award (Hagemeier, PI) Drs. Hagemeier, Alamian, Murawski, and Pack declare no direct or indirect sources of funding with tobacco, alcohol, pharmaceutical, or gaming industries or any body substantially funded by one of these agencies.
Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - Community pharmacists in the United States have significant opportunity to engage in community-level prescription substance abuse prevention and treatment efforts, including dissemination of information specific to available addiction treatment options. Our cross-sectional study of Tennessee community pharmacists noted that 26% had previously provided addiction treatment facility information to one or more patients in the past. The purpose of this study was to employ multivariate modeling techniques to investigate associations between community pharmacist and community pharmacy factors and past provision of addiction treatment information to pharmacy patients. Multivariate logistic regression indicated having addiction treatment facility information in a pharmacy setting (aOR = 8.19; 95% CI. = 4.36-15.37), having high confidence in ability to discuss treatment facility options (aOR. = 4.16; 95% CI. = 2.65-6.52), having participated in prescription opioid abuse-specific continuing education (aOR = 2.90; 95% CI. = 1.70-4.97), being male (aOR = 2.23; 95% CI. = 1.38-3.59), and increased hours per week in the practice setting (aOR = 1.02; 95% CI. = 1.004-1.05) were all significantly associated with provision of information about addiction treatment. Dissemination of addiction treatment information, improvements in communicative self-efficacy beliefs, and dissemination of prescription opioid abuse-specific continuing education are modifiable factors significantly associated with increased provision of addiction treatment information by community pharmacists.
AB - Community pharmacists in the United States have significant opportunity to engage in community-level prescription substance abuse prevention and treatment efforts, including dissemination of information specific to available addiction treatment options. Our cross-sectional study of Tennessee community pharmacists noted that 26% had previously provided addiction treatment facility information to one or more patients in the past. The purpose of this study was to employ multivariate modeling techniques to investigate associations between community pharmacist and community pharmacy factors and past provision of addiction treatment information to pharmacy patients. Multivariate logistic regression indicated having addiction treatment facility information in a pharmacy setting (aOR = 8.19; 95% CI. = 4.36-15.37), having high confidence in ability to discuss treatment facility options (aOR. = 4.16; 95% CI. = 2.65-6.52), having participated in prescription opioid abuse-specific continuing education (aOR = 2.90; 95% CI. = 1.70-4.97), being male (aOR = 2.23; 95% CI. = 1.38-3.59), and increased hours per week in the practice setting (aOR = 1.02; 95% CI. = 1.004-1.05) were all significantly associated with provision of information about addiction treatment. Dissemination of addiction treatment information, improvements in communicative self-efficacy beliefs, and dissemination of prescription opioid abuse-specific continuing education are modifiable factors significantly associated with increased provision of addiction treatment information by community pharmacists.
KW - Addiction treatment
KW - Communication
KW - Community pharmacist
UR - http://www.scopus.com/inward/record.url?scp=84925934525&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925934525&partnerID=8YFLogxK
U2 - 10.1016/j.jsat.2014.11.006
DO - 10.1016/j.jsat.2014.11.006
M3 - Article
C2 - 25491734
AN - SCOPUS:84925934525
VL - 52
SP - 67
EP - 72
JO - Journal of Substance Abuse Treatment
JF - Journal of Substance Abuse Treatment
SN - 0740-5472
ER -
